Registration of Treasury Shares
Faron Pharmaceuticals Ltd. has registered 21,469,427 treasury shares in the Finnish Trade Register on June 8, 2026, to prepare for future bond conversions. Following this registration, the company's total ordinary shares stand at 227,881,315, with 25,000,000 held in treasury. These treasury shares, which do not confer shareholder rights, will be listed on First North on June 12, 2026, and on AIM around June 17, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | June 11, 2026 at 17:00:00 EEST |
Capitalised terms used in this announcement have the meanings given to them in the announcement made on 28 May 2026 at 15:35 EEST regarding the issue of treasury shares to the Company, unless the context provides otherwise.
Turku, Finland – Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company developing novel immunotherapies, as announced on 28 May 2026, issued 21,469,427 treasury shares to the Company itself without consideration to further prepare for any future conversions of the First and Second Tranche of Bonds.
In total, 21,469,427 new Treasury Shares in the Company have on 8 June 2026 been registered in the Finnish Trade Register. The treasury shares will rank pari passu in all respects with the existing shares of the Company. Following the registration of new Shares, the aggregate number of ordinary shares in the Company is 227,881,315 and of these shares, the Company holds 25,000,000 shares in treasury. The shares held in treasury by the Company do not confer a right to dividends or other shareholder rights.
The treasury shares will be listed on First North on 12 June 2026 and on AIM on or around 17 June 2026.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.